Intelligent Bio Solutions Highlights Drug Testing Innovation at RISE25

Innovative Solutions for Forensic Drug Testing
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is stepping into the spotlight at the highly regarded RISE25 conference, taking place in sunny Florida. Their participation marks a significant moment as they team up with SMARTOX to share insights on the future of forensic drug testing. This cutting-edge conference draws over 7,000 attendees from various sectors including addiction, mental health, and justice, providing a platform to discuss critical issues impacting communities.
Our Unique Intelligent Fingerprinting Solution
The Intelligent Fingerprinting Drug Testing Solution developed by INBS is gaining traction across sectors where on-site drug testing is essential. The system is not only portable and user-friendly but also ensures results are delivered quickly - typically within ten minutes. This could be a game-changer in treatment courts and probation settings where immediacy in testing is vital.
Quick and Reliable Results
The collection method is discreet, hygienic, and efficient, utilizing sweat from fingerprints to identify recent substance use, such as cannabis, cocaine, methamphetamine, and opiates. In a society where privacy and reliability are paramount, INBS offers a solution that addresses these needs head-on.
Connecting with Key Stakeholders
The upcoming RISE25 conference presents an excellent opportunity for INBS to not only showcase their products but also engage with potential partners and investors who are passionate about promoting health and safety through innovative technology. Harry Simeonidis, President and CEO, alongside Doug Heath, Vice President of Global Sales, will showcase this revolutionary technology during the conference.
Transforming Justice Responses
Doug Heath has expressed the importance of this conference, stating that it signifies a national movement towards reforming justice responses to substance use and mental health issues. INBS is proud to align with SMARTOX, showcasing their commitment to innovative and ethical practices in drug testing solutions.
Commitment to Global Health Standards
Moreover, with more than 450 active accounts across 24 countries, Intelligent Bio Solutions is positioned to meet the growing demand for cutting-edge, reliable drug testing solutions globally. Their focus on developing non-invasive and intelligent screening methods reflects their commitment to health and safety standards that transcend borders.
Exploring a Rapidly Growing Market
As INBS pursues FDA approval for their Intelligent Fingerprinting Drug Screening System, they are also looking at various avenues to expand in the Forensic Use Only market in the U.S. This market not only offers significant growth potential but also aligns perfectly with their mission to enhance public safety through innovative technology solutions.
About SMARTOX and Collaborative Efforts
SMARTOX, founded in 2012, is a respected player in the drug and alcohol testing sector. Their comprehensive range of services caters to various industries such as healthcare, corporate, and education, making them the perfect partner for INBS. With a focus on delivering advanced technology, SMARTOX enhances INBS's offerings in the drug testing landscape.
About Us: Intelligent Bio Solutions Inc.
Founded to transform the landscape of medical testing, Intelligent Bio Solutions Inc. harnesses the power of rapid, non-invasive testing technology. Their innovative Intelligent Fingerprinting Drug Screening System is aiming to revolutionize how drug use is monitored, enabling rapid screening that can cater to multiple industries.
A Vision for the Future
The future looks promising, with the potential for applications in fields beyond typical workplace settings. Whether it's in construction, transportation, or healthcare, the ability to screen for drugs effectively and efficiently could lead to improved safety and better health outcomes.
Frequently Asked Questions
1. What does Intelligent Bio Solutions do?
Intelligent Bio Solutions develops innovative testing solutions, particularly for drug screening through fingerprint analysis.
2. What is the significance of the RISE25 conference?
RISE25 is a prominent event focused on addiction, mental health, and justice, allowing professionals to share insights and innovations.
3. How quickly can results from the Intelligent Fingerprinting Drug Testing System be obtained?
Results from the system can be obtained in under ten minutes, providing rapid feedback for crucial decisions.
4. In what industries is the fingerprint drug testing applicable?
The testing solution can be applied in workplaces, treatment courts, probation programs, and more, addressing multiple needs.
5. How many active accounts does INBS have globally?
Intelligent Bio Solutions currently has over 450 active accounts spanning across 24 countries.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.